Loading...
Loading...
CLGN| Name | Value |
|---|---|
| Revenues | 10.2M |
| Cost of Revenue | 0.6M |
| Gross Profit | 9.6M |
| Operating Expense | 3.9M |
| Operating I/L | 5.7M |
| Other Income/Expense | 0.1M |
| Interest Income | 0.1M |
| Pretax | 5.8M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | 5.8M |
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company specializing in 3D bioprinting of tissues and organs, and medical aesthetics. The company's products are based on recombinant type I human collagen produced with proprietary plant-based genetic engineering technology. Its offerings include BioInks for 3D printing, dermal and soft tissue fillers, 3D bioprinted breast implants, injectable implants, regenerative soft tissue matrix, VergenixSTR for soft tissue repair, and VergenixFG for advanced wound care. CollPlant generates revenue through the sale of these innovative bioprinting and aesthetic medicine products, as well as through collaboration agreements with industry partners.
